Literature DB >> 31335806

Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.

Emily Cedarbaum1, Yifei Ma, Rebecca Scherzer, Jennifer C Price, Adaora A Adimora, Marcas Bamman, Mardge Cohen, Margaret A Fischl, Kunihiro Matsushita, Igho Ofotokun, Michael Plankey, Eric C Seaberg, Michael T Yin, Carl Grunfeld, Shant Vartanian, Anjali Sharma, Phyllis C Tien.   

Abstract

OBJECTIVES: HIV and hepatitis C virus (HCV) have been associated with cardiovascular disease (CVD), but it is unclear whether HIV and HCV are also associated with peripheral artery disease (PAD). We examined the association of HIV, HCV, and traditional CVD risk factors with PAD in the Women's Interagency HIV Study, a multicenter US cohort.
METHODS: In this cross-sectional study, ankle-brachial index was estimated using Doppler ultrasound and manual sphygmomanometer in 1899 participants aged more than 40 years with HIV/HCV coinfection, HCV or HIV monoinfection, or neither infection. Multivariable logistic regression was used to estimate the odds of PAD (ankle-brachial index ≤0.9) after controlling for demographic, behavioral, and CVD risk factors.
RESULTS: Over two-thirds were African-American, median age was 50 years, and PAD prevalence was 7.7% with little difference by infection status. After multivariable adjustment, neither HIV nor HCV infection was associated with greater odds of PAD. Factors associated with PAD included older age [adjusted odds ratio (aOR): 2.01 for age 61-70 vs. 40-50 years; 95% confidence interval (CI): 1.04, 3.87], Black race (aOR: 2.30; 95% CI: 1.15, 4.63), smoking (aOR: 1.27 per 10-pack-year increment; 95% CI: 1.09, 1.48), and higher SBP (aOR: 1.14 per 10 mmHg; 95% CI: 1.01, 1.28).
CONCLUSION: The high PAD prevalence in this nationally representative cohort of women with or at risk for HIV is on par with general population studies in individuals a decade older than our study's median age. HIV and HCV infection are not associated with greater PAD risk relative to uninfected women with similar risk factors. Modifiable traditional CVD risk factors may be important early intervention targets in women with and at risk for HIV.

Entities:  

Mesh:

Year:  2019        PMID: 31335806      PMCID: PMC6774831          DOI: 10.1097/QAD.0000000000002319

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  42 in total

1.  Ethnic-specific prevalence of peripheral arterial disease in the United States.

Authors:  Matthew A Allison; Elena Ho; Julie O Denenberg; Robert D Langer; Anne B Newman; Richard R Fabsitz; Michael H Criqui
Journal:  Am J Prev Med       Date:  2007-04       Impact factor: 5.043

Review 2.  Ankle-brachial index as a marker of cognitive impairment and dementia in general population. A systematic review.

Authors:  Maëlenn Guerchet; Victor Aboyans; Philippe Nubukpo; Philippe Lacroix; Jean-Pierre Clément; Pierre-Marie Preux
Journal:  Atherosclerosis       Date:  2011-03-25       Impact factor: 5.162

3.  Low prevalence of peripheral arterial disease in HIV-infected patients with multiple cardiovascular risk factors.

Authors:  Enrique Bernal; Mar Masiá; Sergio Padilla; Ildefonso Hernández; Félix Gutiérrez
Journal:  J Acquir Immune Defic Syndr       Date:  2008-01-01       Impact factor: 3.731

4.  Inflammation, immune activation, and CVD risk in individuals with HIV infection.

Authors:  James H Stein; Priscilla Y Hsue
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

Review 5.  Epidemiology of peripheral artery disease.

Authors:  Michael H Criqui; Victor Aboyans
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 6.  Peripheral artery disease: epidemiology and global perspectives.

Authors:  F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

7.  Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.

Authors:  Sarah H Wild; Christopher D Byrne; Felicity B Smith; Amanda J Lee; F Gerald R Fowkes
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

8.  Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study.

Authors:  A W Tsai; A R Folsom; W D Rosamond; D W Jones
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

9.  Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis.

Authors:  Victor Aboyans; Robyn L McClelland; Matthew A Allison; Mary McGrae McDermott; Roger S Blumenthal; Katarzyna Macura; Michael H Criqui
Journal:  Atherosclerosis       Date:  2010-10-21       Impact factor: 5.162

10.  A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.

Authors:  Birgitta Sigvant; Katarina Wiberg-Hedman; David Bergqvist; Olov Rolandsson; Bob Andersson; Elisabeth Persson; Eric Wahlberg
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

View more
  5 in total

1.  The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.

Authors:  Andrew L Callen; Sara M Dupont; Jeffrey Pyne; Jason Talbott; Phyllis Tien; Evan Calabrese; David Saloner; Felicia C Chow; Jared Narvid
Journal:  J Neurovirol       Date:  2020-06-04       Impact factor: 2.643

2.  Peripheral artery disease and physical function in women with and without HIV.

Authors:  Emily R Cedarbaum; Yifei Ma; Adaora A Adimora; Marcas Bamman; Mardge H Cohen; Margaret A Fischl; Deborah Gustafson; Kunihiro Matsushita; Igho Ofotokun; Michael Plankey; Eric C Seaberg; Anjali Sharma; Phyllis C Tien
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.177

Review 3.  Cardiovascular Implications of Immune Disorders in Women.

Authors:  Caitlin A Moran; Lauren F Collins; Nour Beydoun; Puja K Mehta; Yetunde Fatade; Ijeoma Isiadinso; Tené T Lewis; Brittany Weber; Jill Goldstein; Igho Ofotokun; Arshed Quyyumi; May Y Choi; Kehmia Titanji; Cecile D Lahiri
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

Review 4.  Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review.

Authors:  Natalie E Chichetto; Brittanny M Polanka; Kaku A So-Armah; Minhee Sung; Jesse C Stewart; John R Koethe; E Jennifer Edelman; Hilary A Tindle; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.495

Review 5.  HIV and cardiovascular disease.

Authors:  Kaku So-Armah; Laura A Benjamin; Gerald S Bloomfield; Matthew J Feinstein; Priscilla Hsue; Benson Njuguna; Matthew S Freiberg
Journal:  Lancet HIV       Date:  2020-04       Impact factor: 16.070

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.